Marimed Inc. splits its revenue into 3 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Product Sales Retail at $23.2 million, 55% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
164
|
42
|
39
|
42
|
41
|
40
|
38
|
39
|
41
|
| Product Sales Retail |
—
|
23
+4.0%
share 55.4%
|
22
+4.8%
share 55.0%
|
—
|
23
-3.5%
share 55.4%
|
22
share 56.5%
|
21
share 54.7%
|
—
|
23
share 57.6%
|
| Product Sales Wholesale |
—
|
19
+8.1%
share 44.2%
|
18
+4.4%
share 44.4%
|
18
+8.8%
share 42.3%
|
18
+10.6%
share 44.2%
|
17
share 43.4%
|
17
share 44.3%
|
16
share 41.6%
|
16
share 40.2%
|
| Other Revenue |
—
|
0
+370.7%
share 0.5%
|
0
-39.2%
share 0.6%
|
—
|
0
-82.2%
share 0.4%
|
0
share 0.1%
|
0
share 1.0%
|
—
|
1
share 2.2%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- MRMD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Norwood, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1522767
- Former names
- WORLDS ONLINE INC. (until May 15, 2017)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.